Delivery Order SPE2DP23D0001-SPE2D625F4LL5
- Not listed
- The U.S. Department of Defense, through its Medical Supply Chain office, awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 27, 2025, with an ultimate completion date of August 11, 2025. The contract calls for the delivery of Reactive Skin Decontamination Lotion, a critical medical countermeasure used by the military for protection against chemical, biological, radiological, and nuclear threats. CCC, a Canadian Crown corporation that specializes...
- The Defense Department's Medical Supply Chain division awarded a $2,090.49 firm fixed-price delivery order to Canadian Commercial Corporation (CCC) on May 20, 2025, with an ultimate completion date of August 5, 2025. This delivery order, contract number 4568321059, represents a child contract with no set-aside designation and will be performed in Ottawa, Ontario, Canada. CCC, a Crown corporation that serves as an intermediary facilitating government-to-government contracting between U.S. federal...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,090.49 firm fixed-price delivery order (Contract No. 4568409126) to Canadian Commercial Corporation (CCC) on May 30, 2025, with an ultimate completion date of August 14, 2025. This delivery order, which carries no set-aside designation, represents a task order under CCC's existing contract vehicle and leverages the corporation's established government-to-government contracting relationship with U.S. defense agencies. CCC, a Crown...
- The U.S. Department of Defense's Medical Supply Chain awarded a $104.5K delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Reactive Skin Decontamination Lotion. This contract represents a firm fixed-price delivery order with an ultimate completion date of December 18, 2025, and carries no set-aside designation. The work will be performed in Ottawa, Ontario, Canada, reflecting CCC's role as a Crown corporation that serves as an intermediary facilitating...
- This is a $792,000.00 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to the Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting. The order is for Reactive Skin Decontamination Lotion, which CCC is providing as the prime contractor. CCC has subcontracted the manufacturing of the lotion to Emergent Biosolutions Canada Inc., a for-profit...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract, valued at $1,099.24 with a firm fixed price structure, represents a child delivery order with an ultimate completion date of December 18, 2025. The work will be performed at CCC's facility located in Ottawa, Ontario, Canada. No set-aside designation was utilized for this procurement, consistent with...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $41,221.50 to Canadian Commercial Corporation (CCC) on October 2, 2025, for Inactive Skin Decontamination Lotion 21. This contract is a child delivery order under a larger indefinite delivery vehicle and utilizes firm fixed-price pricing with no set-aside designation. Performance will be completed by December 18, 2025, with work to be performed at CCC's facility in Ottawa, Ontario, Canada. The Reactive...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Canadian Commercial Corporation (CCC) on October 2, 2025, for the supply of Inactive Skin Decontamination Lotion 21. This contract, valued at $1,648.86, is a firm fixed-price delivery order with an ultimate completion date of December 18, 2025. The contract carries no set-aside designation, reflecting CCC's role as a Crown corporation facilitating government-to-government contracting between U.S. federal agencies and...
- This is a $532,282.95 firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation (CCC), a Crown corporation owned by the Government of Canada. The contract is for the delivery of reactive skin decontamination lotion, with performance occurring in Ottawa, Ontario, Canada. CCC acts as a prime contractor to U.S. federal agencies, particularly the Department of Defense, providing a wide array of goods and services...
- This is a $2,198,121.00 delivery order awarded by the Defense Logistics Agency Troop Support Medical to Canadian Commercial Corporation, a Crown corporation owned by the Government of Canada that facilitates military exports and international contracting opportunities for Canadian companies. The order is for Reactive Skin Decontamination Lotion and has a completion date of August 2, 2018. Canadian Commercial Corporation is serving as the prime contractor and has subcontracted the manufacturing...
- SPE2DP23D0001Indefinite Delivery Contract
- SPE2DP23D0001-SPE2D625F4LL5Delivery Order
The Defense Department's Medical Supply Chain funded this $2,090.49 delivery order to Canadian Commercial Corporation (CCC), a Crown corporation that serves as a prime contractor facilitating government-to-government procurement between U.S. federal agencies and Canadian exporters. Awarded on June 30, 2025, with an ultimate completion date of September 12, 2025, this firm fixed-price contract requires no set-aside designation and represents a child contract under a larger vehicle. The work will be performed at CCC's facility in Ottawa, Ontario, Canada. Under this delivery order, CCC is procuring Reactive Skin Decontamination Lotion through subcontractor Emergent Biosolutions Canada Inc., a medical countermeasures provider specializing in chemical, biological, radiological, and nuclear threat mitigation. Emergent Biosolutions, which has received over $770 million in federal contracts from defense and health agencies for medical countermeasures including skin decontamination products and biological therapeutics, will manufacture the decontamination lotion for delivery to support U.S. defense operations and personnel protection requirements.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
105929633S | Emergent Biosolutions Canada Inc. | Delivery Order SPE2DP23D0001-SPE2D625F4LL5 | $0 | 6/30/25 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/30/25 |